JP2012097028A - Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent - Google Patents

Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent Download PDF

Info

Publication number
JP2012097028A
JP2012097028A JP2010245780A JP2010245780A JP2012097028A JP 2012097028 A JP2012097028 A JP 2012097028A JP 2010245780 A JP2010245780 A JP 2010245780A JP 2010245780 A JP2010245780 A JP 2010245780A JP 2012097028 A JP2012097028 A JP 2012097028A
Authority
JP
Japan
Prior art keywords
agent
extract
action
added
effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010245780A
Other languages
Japanese (ja)
Inventor
Koichiro Tamura
耕一郎 田村
Kaori Tobe
香織 戸部
Hiroko Yoshida
浩子 吉田
Kentaro Yagi
健太郎 八木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noevir Co Ltd
Original Assignee
Noevir Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noevir Co Ltd filed Critical Noevir Co Ltd
Priority to JP2010245780A priority Critical patent/JP2012097028A/en
Publication of JP2012097028A publication Critical patent/JP2012097028A/en
Pending legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide an anti-aging agent, an anti-oxidant, an arginase activity accelerator, a slimming agent and a whitening agent which exhibit high anti-aging effect, anti-oxidation effect, arginase activity acceleration effect, slimming effect and whitening effect.SOLUTION: The anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent comprise the extract of Hosta sieboldii var. rectifolia as an active ingredient.

Description

本発明は、高い抗老化効果、抗酸化効果、アルギナーゼ活性促進効果、痩身効果、および美白効果を発揮する抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤に関する。   The present invention relates to an anti-aging agent, an antioxidant, an arginase activity promoter, a slimming agent, and a whitening agent that exhibit a high anti-aging effect, antioxidant effect, arginase activity promoting effect, slimming effect, and whitening effect.

従来より、皮膚の美観を保つことに対する女性の関心は非常に高く、シワ、シミ、タルミなどは女性の肌に対する悩みの上位に常に位置する。これらの悩みのうち、シワやタルミは、加齢等による真皮線維芽細胞の機能低下や、それに伴うコラーゲンやエラスチン等の真皮マトリックスの減少や変性、さらには紫外線等の外来ストレスによる酸化障害などが重要な要因となっている。また、もう一方の大きな悩みである皮膚の黒化は、一部不明な点もあるがホルモンの異常や日光の紫外線の刺激によるメラニン色素の産生が原因であり、その中でも、シミやソバカスはメラニン色素が異常沈着することが、その要因である。   Conventionally, women's interest in maintaining the aesthetics of the skin is very high, and wrinkles, spots, tarmi, etc. are always at the top of women's skin problems. Among these wrinkles, wrinkles and tarmi have decreased dermal fibroblast function due to aging, etc., accompanied by decrease or degeneration of dermal matrix such as collagen and elastin, and oxidative damage due to external stress such as ultraviolet rays. It is an important factor. The other big problem is the darkening of the skin, although there are some unclear points, it is caused by hormonal abnormalities and the production of melanin by stimulation of ultraviolet rays of sunlight. Among them, spots and buckwheat are melanin. The cause is abnormal pigmentation.

これまでにも、上述の皮膚の美観を損なうような諸症状を防止、或いは改善するために、さまざまな細胞賦活剤や抗酸化剤、メラニン産生抑制剤の検索および配合検討が成されてきた。   So far, various cell activators, antioxidants, and melanin production inhibitors have been searched and formulated for the purpose of preventing or ameliorating various symptoms that impair the above-described skin aesthetics.

例えば、細胞賦活剤としては、ポンカンのエッセンス(特許文献1参照)、ツリガネニンジン属、クサギおよびそれらの抽出物(特許文献2参照)、有機溶媒によるクロレラ抽出物(特許文献3参照)等、抗酸化剤としては、キク科ヘテロテカ属植物抽出物(特許文献4参照)やカユンアンギンの抽出物(特許文献5参照)等、さらにメラニン産生抑制剤としては、ホンダワラの抽出物(特許文献6参照)、ショウガ属植物の抽出物(特許文献7参照)等が知られている。   For example, as a cell activator, essence of Ponkan (see Patent Document 1), genus Genus, Wedge and extracts thereof (see Patent Document 2), chlorella extract with an organic solvent (see Patent Document 3), etc., antioxidants As an agent, an extract of a plant belonging to the genus Heteroteca genus (see Patent Document 4) or an extract of Kayunangin (see Patent Document 5) and the like, and as a melanin production inhibitor, an extract of Honda walla (see Patent Document 6), ginger An extract of a genus plant (see Patent Document 7) and the like are known.

特開2001−131045号公報JP 2001-131045 A 特開2000−178198号公報JP 2000-178198 A 特開平11−335293号公報JP 11-335293 A 特開平11−180886号公報JP-A-11-180886 特開平10−182413号公報Japanese Patent Laid-Open No. 10-182413 特開平10−330220号公報JP 10-330220 A

天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも数多くの植物や菌類などが皮膚外用剤や飲食品などの分野に幅広く応用されている。しかし、天然由来成分の中には未だその効果が知られていないものも数多く存在し、優れたアルギナーゼ活性促進作用、細胞賦活作用、抗酸化作用、美白作用などを有する有効成分の開発が期待されていた。本発明は、このような有効成分を見出すためになされたものであり、皮膚外用剤や飲食品などの分野に幅広く応用が可能な抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤を提供することを目的とする。   Naturally-derived components are known to have various pharmacological and cosmetic effects, and so far many plants and fungi have been widely applied to fields such as external preparations for skin and foods and drinks. However, there are many naturally-derived ingredients whose effects are not yet known, and the development of effective ingredients with excellent arginase activity promoting action, cell activation action, antioxidant action, whitening action, etc. is expected. It was. The present invention was made in order to find such an active ingredient, and can be widely applied in the field of external preparations for skin and foods and drinks, an antioxidant, an arginase activity promoter, a slimming agent, And to provide a whitening agent.

本発明者らは、皮膚外用剤や飲食品などの分野に幅広く応用が可能な抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤を見出すために、天然由来の種々の物質について検討を行った。その結果、タチギボウシの抽出物に、優れた抗老化効果、抗酸化効果、アルギナーゼ活性促進効果、痩身効果、および美白効果を見出し、さらに検討を重ね、本発明を完成するに至った。すなわち、本発明は、タチギボウシの抽出物を有効成分として含有する抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤を提供するものである。   In order to find an anti-aging agent, an antioxidant, an arginase activity promoter, a slimming agent, and a whitening agent that can be widely applied to fields such as external preparations for skin and foods and beverages, the present inventors The substance was examined. As a result, an excellent anti-aging effect, antioxidant effect, arginase activity promoting effect, slimming effect, and whitening effect were found in the extract of the prickly cattle, and further studies were made to complete the present invention. That is, the present invention provides an anti-aging agent, an antioxidant, an arginase activity promoter, a slimming agent, and a whitening agent, which contains an extract of a spotted bovine as an active ingredient.

本発明によれば、優れた効果を有する抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤を提供することができる。   ADVANTAGE OF THE INVENTION According to this invention, the anti-aging agent, antioxidant, arginase activity promoter, slimming agent, and whitening agent which have the outstanding effect can be provided.

本発明の原料として用いられる植物であるタチギボウシ(Hosta rectifolia NakaiHosta siebordii)は、ユリ科ギボウシ属に属する草本で、北海道から本州、九州に広くに分布する。 A plant used as a raw material of the present invention, Hostectobori Nakai ( Hosta lectifolia Nakai ), is a herb belonging to the genus Liboaceae and is widely distributed from Hokkaido to Honshu and Kyushu.

本発明において、タチギボウシは原体や乾燥物を用いてもよいが、各種溶媒を用いて抽出した抽出物を用いるのが好ましい。抽出には、タチギボウシの茎、葉、花、種子、根、地下茎、果実、芽などのいずれの部位を用いても構わないが、有効性の点からは全草を用いるとよい。抽出の際は、生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。抽出は、抽出溶媒に浸漬するか、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効率を上げるため、撹拌や抽出溶媒中でホモジナイズしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが適切である。   In the present invention, the active body or the dried product may be used for the prickly cattle, but it is preferable to use extracts extracted using various solvents. For extraction, any part of the stem, leaves, flowers, seeds, roots, rhizomes, fruits, buds, etc. of the prickly cattle may be used, but whole plants may be used from the viewpoint of effectiveness. In the extraction, it may be used as it is, but considering the extraction efficiency, it is preferable to perform the extraction after performing processing such as shredding, drying, and pulverization. The extraction can be performed by immersing in an extraction solvent or by an extraction method using a supercritical fluid or a subcritical fluid. In order to increase the extraction efficiency, the mixture may be homogenized in stirring or an extraction solvent. The extraction temperature is suitably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but it is appropriate to set it to about 1 hour to 14 days.

抽出溶媒としては、水の他、メタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール、1、3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール、エチルエーテル、プロピルエーテル等のエーテル類、酢酸ブチル、酢酸エチル等のエステル類、アセトン、エチルメチルケトン等のケトン類などの溶媒を用いることができ、これらより1種又は2種以上を選択して用いる。また、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種又は2種以上の超臨界流体や亜臨界流体を用いてもよい。   Extraction solvents include water, lower alcohols such as methanol, ethanol, propanol and isopropanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin, ethers such as ethyl ether and propyl ether. And solvents such as esters such as butyl acetate and ethyl acetate, and ketones such as acetone and ethyl methyl ketone can be used, and one or more of these can be selected and used. Further, physiological saline, phosphate buffer, phosphate buffered saline, or the like may be used. Furthermore, you may use 1 type, or 2 or more types of supercritical fluids and subcritical fluids, such as water, a carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia.

タチギボウシの上記溶媒による抽出物は、そのままでも使用することができるが、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもでき、これらの生理作用を損なわない範囲で脱色、脱臭、脱塩等の精製処理やカラムクロマトグラフィー等による分画処理を行った後に用いてもよい。タチギボウシの前記抽出物やその処理物および分画物は、各処理および分画後に凍結乾燥し、用時に溶媒に溶解して用いることもできる。   The extract of the above-mentioned solvent of the prickly cattle can be used as it is, but the concentrated and dried product can be used again by dissolving it in water or a polar solvent, and it is decolorized as long as these physiological functions are not impaired. It may be used after a purification treatment such as deodorization and desalting or a fractionation treatment by column chromatography or the like. The above-mentioned extract of Tachigiboushi, its processed products and fractions can be freeze-dried after each treatment and fractionation and dissolved in a solvent before use.

タチギボウシの抽出物は、優れた抗老化作用、抗酸化作用、アルギナーゼ活性促進作用、痩身作用、および美白作用を有し、タチギボウシの抽出物を有効成分として含有する抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤として利用することができる。タチギボウシの抽出物を有効成分とする抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤は、皮膚に外用するだけではなく、毛髪に利用することや経口摂取も可能であり、食品、飲料、あるいは医薬品などにも応用することが可能である。   The extract of Tachigiboushi has excellent anti-aging action, antioxidant action, arginase activity promoting action, slimming action, and whitening action, and contains anti-aging agent, antioxidant, arginase containing Tachigiboushi extract as an active ingredient It can be used as an activity promoter, slimming agent, and whitening agent. Anti-aging agents, antioxidants, arginase activity promoters, slimming agents, and whitening agents, which are made from Tachigiboushi extract as an active ingredient, can be used not only for the skin but also for hair and can be taken orally. It can also be applied to foods, beverages, pharmaceuticals, and the like.

タチギボウシの抽出物は、細胞賦活作用(抗老化作用)、コラーゲン産生促進作用(抗老化作用)、スーパーオキサイドアニオン消去能(抗酸化作用)、フリーラジカル消去能(抗酸化作用)、過酸化脂質耐性促進作用(抗酸化作用)、アルギナーゼ活性促進作用、中性脂肪蓄積抑制作用(痩身作用)、チロシナーゼ活性阻害作用(美白作用)、メラニン産生抑制作用(美白作用)を発揮し、抗老化剤、抗酸化剤、アルギナーゼ活性促進剤、痩身剤、および美白剤として有用である。   Tachigibobo extract has cell activation (anti-aging), collagen production promotion (anti-aging), superoxide anion scavenging (antioxidant), free radical scavenging (antioxidant), lipid peroxide resistance Demonstrates promoting action (antioxidant action), arginase activity promoting action, neutral fat accumulation inhibiting action (slimming action), tyrosinase activity inhibiting action (whitening action), melanin production inhibiting action (whitening action) Useful as an oxidizing agent, arginase activity promoter, slimming agent, and whitening agent.

以下にタチギボウシ抽出物の製造例、各作用を評価するための試験についてさらに詳細に説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。   Hereinafter, production examples of the guinea pig extract and tests for evaluating each action will be described in more detail. However, the technical scope of the present invention is not limited thereto.

[抽出物1]
タチギボウシの茎、蕾、花、新芽を含む地上部位全草の乾燥粉砕物100gを、2.0kgの熱水で20分間加熱抽出した。抽出上清を濾別したのち、凍結乾燥を行い、抽出物1を得た。
[Extract 1]
100 g of the dry ground pulverized material of the ground plant including stems, buds, flowers, and sprouts of the prickly cattle was heated and extracted with 2.0 kg of hot water for 20 minutes. The extract supernatant was filtered and lyophilized to obtain extract 1.

[抽出物2]
タチギボウシの茎、蕾、花、新芽を含む地上部位全草の乾燥粉砕物100gを、2.0kgの50容量%エタノール水溶液に、分散させ、撹拌しながら室温にて2時間抽出した。抽出上清を濾別したのち、減圧濃縮後、凍結乾燥を行い、抽出物2を得た。
[Extract 2]
100 g of a dry pulverized product of the above-ground whole plant including stems, buds, flowers and shoots of Tachigiboushi was dispersed in 2.0 kg of 50 vol% ethanol aqueous solution and extracted at room temperature for 2 hours with stirring. The extract supernatant was filtered off, concentrated under reduced pressure, and lyophilized to obtain extract 2.

[抽出物3]
タチギボウシの茎、蕾、花、新芽を含む地上部位全草の乾燥粉砕物を耐圧セルに投入し、液化二酸化炭素をポンプで連続的に流し込み、25MPa、5mL/min、40℃の条件下でそのまま二酸化炭素を流し、抽出成分を気液分離器内に集めて抽出物を得た。
[Extract 3]
A dry pulverized product of whole ground plant including stems, buds, flowers, and shoots of prickly cattle is put into a pressure cell, and liquefied carbon dioxide is continuously poured by a pump, and the conditions are kept under conditions of 25 MPa, 5 mL / min, and 40 ° C. Carbon dioxide was allowed to flow, and the extract components were collected in a gas-liquid separator to obtain an extract.

上記抽出物1、抽出物2、抽出物3を用いて、真皮線維芽細胞賦活作用、真皮線維芽細胞I型コラーゲン産生促進作用、ヒト表皮角化細胞賦活作用、スーパーオキサイドアニオン消去作用、DPPHラジカル消去能、表皮細胞を用いた過酸化脂質耐性向上作用、アルギナーゼ活性促進作用、中性脂肪蓄積抑制作用、ヒト表皮メラニン細胞を用いたチロシナーゼ活性阻害作用、メラニン産生抑制作用の評価を行った。なお各評価結果に記載した*および**は、t検定における有意確率P値に対し、有意確率5%未満(P<0.05)を*で、有意確率1%未満(P<0.01)を**でそれぞれ表したものである。   Using the above extract 1, extract 2 and extract 3, dermal fibroblast activation action, dermal fibroblast type I collagen production promotion action, human epidermal keratinocyte activation action, superoxide anion scavenging action, DPPH radical The evaluation was made on the erasing ability, lipid peroxide resistance improving action using epidermal cells, arginase activity promoting action, neutral fat accumulation inhibiting action, tyrosinase activity inhibiting action using human epidermal melanocytes, and melanin production inhibiting action. Note that * and ** described in each evaluation result indicate that the significance probability P value in the t-test is less than 5% (P <0.05), and less than 1% significance (P <0.01). ) Is represented by **.

[抗老化作用:ヒト真皮線維芽細胞賦活作用]
正常ヒト真皮線維芽細胞を1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には1質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間培養後、表1に示す各濃度となるよう抽出物3を添加した1質量%FBS添加DMEM培地に交換し、さらに48時間培養した。次に400μg/mLとなるよう培地にて調整したMTT試薬を、上清を除いた細胞に添加し、約2時間培養した。最後に2−プロパノールにて生じたフォルマザンを抽出し、550nmの吸光度を測定した。同時に濁度として650nmの吸光度を測定し、両測定値の差を用いて細胞賦活作用を評価した。評価結果を、試料無添加のコントロールにおける細胞賦活作用を100とした相対値にて表1に示す。
[Anti-aging effect: human dermal fibroblast activation effect]
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 1% by weight fetal bovine serum (FBS) was used as the seeding medium. After culturing for 24 hours, the medium was replaced with 1% by mass FBS-added DMEM medium to which the extract 3 was added so as to have each concentration shown in Table 1, and further cultured for 48 hours. Next, the MTT reagent adjusted with the culture medium so that it might become 400 micrograms / mL was added to the cell except the supernatant, and it culture | cultivated for about 2 hours. Finally, formazan produced in 2-propanol was extracted and the absorbance at 550 nm was measured. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated using the difference between the two measured values. The evaluation results are shown in Table 1 as relative values with the cell activation effect in the control with no sample added being taken as 100.

Figure 2012097028
Figure 2012097028

表1より明らかなように、タチギボウシ抽出物を添加した培地では、有意な真皮線維芽細胞賦活作用を示すことが明らかとなった。   As is clear from Table 1, it was revealed that the medium supplemented with the guinea pig extract exhibits a significant dermal fibroblast activation effect.

[抗老化作用:ヒト真皮線維芽細胞I型コラーゲン産生促進作用]
正常ヒト真皮線維芽細胞を1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間培養後、表2に示す各濃度となるように抽出物1を添加した0.5質量%FBS添加DMEM培地に交換し、さらに24時間培養した。培養上清中に分泌されたタイプIコラーゲンの定量にはELISA法を用い、最後は標識されたペルオキシダーゼに対し2,2’−アジノビス(3−エチルベンゾチアゾリン−6−スルホン酸)ジアンモニウム塩(ABTS)及び過酸化水素を添加し反応させた後、405nmの吸光度を測定した。PIERCE社製BCA Protein Assay Kitにて各ウェルのタンパク量を測定し、単位タンパク量当りのタイプIコラーゲン産生量を求めた。評価結果を試料無添加のコントロールにおける単位タンパク量当りのタイプIコラーゲン産生量を100とした時の相対値にて表2に示す。
[Anti-aging effect: human dermal fibroblast type I collagen production promoting effect]
Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After culturing for 24 hours, the culture medium was replaced with 0.5% by mass FBS-added DMEM medium to which the extract 1 was added so as to have each concentration shown in Table 2, and further cultured for 24 hours. The ELISA method was used for the quantification of type I collagen secreted into the culture supernatant. Finally, 2,2′-azinobis (3-ethylbenzothiazoline-6-sulfonic acid) diammonium salt ( ABTS) and hydrogen peroxide were added and reacted, and then the absorbance at 405 nm was measured. The amount of protein in each well was measured with BCA Protein Assay Kit manufactured by PIERCE, and the amount of type I collagen produced per unit protein was determined. The evaluation results are shown in Table 2 as relative values when the type I collagen production amount per unit protein amount in the control with no sample added is defined as 100.

Figure 2012097028
Figure 2012097028

表2より明らかなように、タチギボウシ抽出物を添加した培地では、有意な真皮線維芽細胞I型コラーゲン産生促進作用を示すことが明らかとなった。   As is clear from Table 2, it was revealed that the medium supplemented with the guinea pig extract exhibits a significant dermal fibroblast type I collagen production promoting action.

[抗老化作用:ヒト表皮角化細胞賦活作用]
ヒト表皮角化細胞HaCaTを1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間培養後、表3に示す各濃度となるように抽出物2を添加した5質量%FBS添加DMEM培地に交換し、さらに24時間培養した。次に100μg/mLとなるよう培地にて調整したMTT試薬を、上清を除いた細胞に添加し、約2時間培養した。最後に2−プロパノールにて生じたフォルマザンを抽出し、550nmの吸光度を測定した。同時に濁度として650nmの吸光度を測定し、両測定値の差を用いて細胞賦活作用を評価した。評価結果を試料無添加のコントロールにおける細胞賦活作用を100とした時の相対値にて表3に示す。
[Anti-aging effect: human epidermal keratinocyte activation effect]
Human epidermal keratinocytes HaCaT were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After culturing for 24 hours, the medium was replaced with 5% by mass FBS-added DMEM medium to which the extract 2 was added so as to have each concentration shown in Table 3, and further cultured for 24 hours. Next, the MTT reagent adjusted with the culture medium so that it might be set to 100 microgram / mL was added to the cell except the supernatant, and it culture | cultivated for about 2 hours. Finally, formazan produced in 2-propanol was extracted and the absorbance at 550 nm was measured. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated using the difference between the two measured values. The evaluation results are shown in Table 3 as relative values when the cell activation effect in the control with no sample added is taken as 100.

Figure 2012097028
Figure 2012097028

表3より明らかなように、タチギボウシ抽出物を添加した培地では、有意なヒト表皮角化細胞賦活作用を示すことが明らかとなった。   As is clear from Table 3, it was revealed that the medium supplemented with the extract of the spotted bovine shows a significant human epidermal keratinocyte activation effect.

表1〜3に示したとおり、タチギボウシ抽出物は、ヒト真皮線維芽細胞賦活作用、ヒト真皮線維芽細胞I型コラーゲン産生促進作用およびヒト表皮角化細胞賦活作用を示すことから、優れた抗老化効果を発揮する。   As shown in Tables 1 to 3, the Tachibo bovine extract exhibits excellent anti-aging because it exhibits a human dermal fibroblast activation effect, a human dermal fibroblast type I collagen production promoting effect and a human epidermal keratinocyte activation effect. Demonstrate the effect.

[抗酸化作用:SOD様活性作用]
抽出物2を、HANK’S(+)溶液にて表4に示す各濃度に調製したサンプル溶液25μLに、0.25mMのWST−1、及び1mMヒポキサンチンを含むHANK’S(+)溶液75μLを添加した。さらに、キサンチンオキシダーゼ25μL(0.0075Units)を添加し、37℃にて15分間反応後、450nmの吸光度を測定した。試料無添加時の吸光度を(A)、試料添加時の吸光度を(B)とした時、スーパーオキサイドアニオン消去率は次式に定義される。
消去率(%)={1−(B)/(A)}×100
評価結果を表4に示す。
[Antioxidant action: SOD-like activity]
Extract 25 was added to a HANK'S (+) solution at a concentration of 25 μL shown in Table 4 in a sample solution of 25 μL, and a HANK ′S (+) solution containing 75 μL of 0.25 mM WST-1 and 1 mM hypoxanthine. Was added. Furthermore, 25 μL (0.0075 Units) of xanthine oxidase was added, and after reacting at 37 ° C. for 15 minutes, the absorbance at 450 nm was measured. When the absorbance when no sample is added is (A) and the absorbance when the sample is added is (B), the superoxide anion elimination rate is defined by the following equation.
Erase rate (%) = {1- (B) / (A)} × 100
The evaluation results are shown in Table 4.

Figure 2012097028
Figure 2012097028

表4より明らかなように、タチギボウシ抽出物は、有意なスーパーオキサイドアニオン消去作用を示すことが明らかとなった。   As is clear from Table 4, it was revealed that the guinea pig extract exhibits a significant superoxide anion scavenging action.

[抗酸化作用:DPPHラジカル消去作用]
抽出物1を50質量%エタノールにて表5に示す各濃度に調整し、96ウェルマイクロプレートに100μLずつ添加した。さらに0.2mMの1,1−ジフェニル−2−ピクリルヒドラジル(DPPH)エタノール溶液を100μLずつ添加し、充分に混合後、室温、暗所にて24時間静置し、DPPHラジカルに由来する516nmの吸光度を測定した。試料無添加時の吸光度を(A)、試料添加時の吸光度を(B)とした時、DPPHラジカル消去率は次式に定義される。
消去率={1−(B)/(A)}×100
評価結果を表5に示す。
[Antioxidant action: DPPH radical scavenging action]
Extract 1 was adjusted to each concentration shown in Table 5 with 50% by mass ethanol, and 100 μL was added to each 96-well microplate. Further, 100 μL of 0.2 mM 1,1-diphenyl-2-picrylhydrazyl (DPPH) ethanol solution was added each time, and after mixing well, left at room temperature in the dark for 24 hours, derived from DPPH radicals Absorbance at 516 nm was measured. When the absorbance when no sample is added is (A) and the absorbance when the sample is added is (B), the DPPH radical elimination rate is defined by the following equation.
Erase rate = {1- (B) / (A)} × 100
The evaluation results are shown in Table 5.

Figure 2012097028
Figure 2012097028

表5より明らかなように、タチギボウシ抽出物は、高いDPPHラジカル消去作用を示すことが明らかとなった。   As is clear from Table 5, it was revealed that the Tachigiboushi extract exhibits a high DPPH radical scavenging action.

[抗酸化作用:表皮細胞の過酸化脂質耐性試験]
ヒト表皮角化細胞HaCaTを1ウェル当り2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地には10質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間培養後、表6に示す各濃度となるように抽出物2を添加した10質量%FBS添加DMEM培地に交換し、さらに24時間培養した。任意濃度のt−ブチルヒドロペルオキシドを添加したHANK’S(+)溶液に交換し、2時間培養した。さらに、150μg/mLニュートラルレッドを含有するPBS(−)に交換し、37℃にて2時間培養した。次に1容量%酢酸を含む50容量%エタノール水溶液に交換し、細胞内に取りこまれたニュートラルレッドを抽出し、抽出液の540nmの吸光度を測定した。評価結果をt−ブチルヒドロペルオキシド無添加のコントロールにおける細胞生存率を100としたときの相対値にて表6に示す。
[Antioxidant action: lipid peroxide resistance test of epidermal cells]
Human epidermal keratinocytes HaCaT were seeded in a 96-well microplate so as to be 2.0 × 10 4 cells per well. Dulbecco's modified Eagle medium (DMEM) supplemented with 10% by weight fetal bovine serum (FBS) was used as the seeding medium. After culturing for 24 hours, the medium was replaced with 10% by mass FBS-added DMEM medium to which the extract 2 was added so as to have each concentration shown in Table 6, and further cultured for 24 hours. The solution was replaced with a HANK'S (+) solution to which an arbitrary concentration of t-butyl hydroperoxide was added, and cultured for 2 hours. Furthermore, it replaced | exchanged for PBS (-) containing 150 microgram / mL neutral red, and culture | cultivated at 37 degreeC for 2 hours. Next, it exchanged for 50 volume% ethanol aqueous solution containing 1 volume% acetic acid, neutral red taken in the cell was extracted, and the light absorbency of 540 nm of the extract was measured. The evaluation results are shown in Table 6 as relative values when the cell viability in the control with no t-butyl hydroperoxide added is taken as 100.

Figure 2012097028
Figure 2012097028

表6より明らかなように、タチギボウシ抽出物を添加した培地では、過酸化脂質を添加した場合の細胞生存率が有意に向上することが明らかとなった。   As is clear from Table 6, it was revealed that the cell viability when lipid peroxide was added was significantly improved in the medium supplemented with the spotted bovine extract.

表4〜6に示したとおり、タチギボウシ抽出物は、スーパーオキサイドアニオン消去作用、DPPHラジカル消去作用および表皮細胞の過酸化脂質耐性向上作用を示すことから、優れた抗酸化効果を発揮する。   As shown in Tables 4 to 6, the guinea pig extract exhibits an excellent antioxidant effect since it exhibits a superoxide anion scavenging action, a DPPH radical scavenging action, and a lipid peroxide resistance improving action on epidermal cells.

[アルギナーゼ活性促進作用]
ヒト皮膚角化細胞を1ウェル当たり2.0×10個となるように96ウェルマイクロプレートに播種した。播種培地にはダルベッコ改変イーグル培地(DMEM)にウシ胎児血清(FBS)を5%添加したものを用いた。24時間後、表7に示す各濃度となるように抽出物2を添加した1.2mMCaClを含む5%FBS添加DMEM培地に交換し、さらに9日間培養した。培地は3日に1回交換した。培養終了後、培養上清を採取し、アルギナーゼ活性促進能の評価を行った。アルギナーゼはアルギニンを加水分解し、オルニチンと尿素を生成する。尿素はウレアーゼによってアンモニアに分解され、アンモニアはペンタシアノニトロシル鉄(III)酸ナトリウム二水和物(ニトロプルシッドナトリウム)存在下でサリチル酸、次亜塩素酸と反応し、インドフェノールが生成する。アルカリ性条件下でインドフェノールの吸収(570nm)を測定し、尿素濃度を求め、アルギナーゼ活性の定量を行った。尿素定量のため、和光純薬社製尿素窒素B−テストワコーを用いて同様の測定を行い、検量線を作成した。また、BCAProteinAssayKitにて、各ウェルのタンパク量を測定し、単位タンパク量あたりのアルギナーゼ活性促進能を求めた。評価結果を試料無添加のコントロールにおける単位タンパク量当りのアルギナーゼ活性を100とした時の相対値にて表7に示す。
[Arginase activity promoting effect]
Human skin keratinocytes were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. As the seeding medium, Dulbecco's modified Eagle medium (DMEM) with 5% fetal bovine serum (FBS) added was used. After 24 hours, the medium was replaced with 5% FBS-added DMEM medium containing 1.2 mM CaCl 2 to which the extract 2 was added so as to have each concentration shown in Table 7, and further cultured for 9 days. The medium was changed once every 3 days. After completion of the culture, the culture supernatant was collected and evaluated for its ability to promote arginase activity. Arginase hydrolyzes arginine to produce ornithine and urea. Urea is decomposed into ammonia by urease, and ammonia reacts with salicylic acid and hypochlorous acid in the presence of sodium pentacyanonitrosyl iron (III) dihydrate (sodium nitroprusside) to produce indophenol. The absorption (570 nm) of indophenol was measured under alkaline conditions, the urea concentration was determined, and the arginase activity was quantified. For determination of urea, the same measurement was performed using urea nitrogen B-Test Wako manufactured by Wako Pure Chemical Industries, and a calibration curve was prepared. Moreover, the protein amount of each well was measured with BCA Protein Assay Kit, and the ability to promote arginase activity per unit protein amount was determined. The evaluation results are shown in Table 7 as relative values when the arginase activity per unit protein amount in the control with no sample added is defined as 100.

Figure 2012097028
Figure 2012097028

表7より明らかなように、タチギボウシ抽出物は、有意なアルギナーゼ活性促進効果を発揮することが明らかとなった。   As is apparent from Table 7, it was revealed that the guinea pig extract exhibits a significant arginase activity promoting effect.

[痩身作用:中性脂肪蓄積抑制作用]
皮下脂肪由来正常ヒト前駆脂肪細胞Cryo HPRAD−SQ(三光純薬株式会社)を1ウェル当り1.0×10個となるように96ウェルマイクロプレートに播種した。播種培地にはPGM培地(10質量%FBS、2mM L−グルタミン、100units/mL ペニシリン、100μg/mL ストレプトマイシン含有)を用いた。細胞がコンフルエントになる直前に抽出物2を添加したPGM−分化用培地(10μg/mL インスリン、1μM デキサメタゾン、200μM インドメタシン、500μM イソブチルメチルキサンチン含有)に交換し、脂肪細胞への分化誘導を行った。分化誘導開始後、コントロール群が成熟して細胞内に多数の脂肪滴が蓄積されるまで、10〜14日間培養した。細胞を回収後、10%中性緩衝ホルムアルデヒド液を用いて細胞を固定した。PBS(−)にて洗浄の後、0.5w/v% オイルレッドO溶液を添加し、37℃で2時間培養した。PBS(−)にて洗浄の後、メタノールを添加し、色素を抽出した。抽出後、マイクロプレートリーダーにて550nmの吸光度を測定した。同時に、濁度として650nmの吸光度を測定し、両測定値の差を用いて中性脂肪蓄積抑制作用の評価を行った。評価結果を試料無添加のコントロールにおける中性脂肪蓄積量を100とした時の相対値にて表8に示す。
[Slimming action: Inhibition of neutral fat accumulation]
Subcutaneous fat-derived normal human preadipocytes Cryo HPRAD-SQ (Sanko Junyaku Co., Ltd.) were seeded on a 96-well microplate so that the number was 1.0 × 10 4 per well. PGM medium (containing 10% by mass FBS, 2 mM L-glutamine, 100 units / mL penicillin, 100 μg / mL streptomycin) was used as the seeding medium. Immediately before the cells became confluent, the medium was replaced with PGM-differentiation medium (containing 10 μg / mL insulin, 1 μM dexamethasone, 200 μM indomethacin, 500 μM isobutylmethylxanthine) supplemented with extract 2 to induce differentiation into adipocytes. After initiation of differentiation induction, the cells were cultured for 10 to 14 days until the control group matured and many lipid droplets accumulated in the cells. After the cells were collected, the cells were fixed using a 10% neutral buffered formaldehyde solution. After washing with PBS (−), 0.5 w / v% Oil Red O solution was added and cultured at 37 ° C. for 2 hours. After washing with PBS (−), methanol was added to extract the dye. After extraction, the absorbance at 550 nm was measured with a microplate reader. At the same time, the absorbance at 650 nm was measured as turbidity, and the neutral fat accumulation inhibitory action was evaluated using the difference between the two measured values. The evaluation results are shown in Table 8 as relative values when the neutral fat accumulation amount in the control with no sample added is defined as 100.

Figure 2012097028
Figure 2012097028

表8より明らかなように、タチギボウシ抽出物は、有意な中性脂肪蓄積抑制作用を示すことから、優れた痩身効果を発揮することが明らかとなった。   As is clear from Table 8, the Tachigiboushi extract exhibits a significant neutral fat accumulation inhibitory action, and thus it has been clarified that it exhibits an excellent slimming effect.

[美白作用:チロシナーゼ活性阻害作用]
正常ヒト表皮メラニン細胞を1ウェル当り3.0×10個となるように96ウェルマイクロプレートに播種した。播種培地にはMedium 154Sを用いた。24時間培養後、表9に示す濃度となるように抽出物1を添加したMedium 154Sに交換し、さらに48時間培養した。次に1質量%Triton−Xを含有するリン酸緩衝液75μLに交換し、細胞を完全に溶解させ、内50μLを粗酵素液として使用した。粗酵素液に基質となる50μLの0.05質量%L−ドーパ含有リン酸緩衝液を加え、37℃で2時間静置した。基質添加直後と反応終了時の405nmの吸光度を測定し、生成されたドーパメラニン量は両測定値の差を次式に導入して求めた。
生成されたドーパメラニン量={(反応後405nm値−反応前405nm値)−2.166}/5.238
また、PIERCE社製BCA Protein Assay Kitにて各ウェルのタンパク量を測定し、単位タンパク量当りのドーパメラニン生成量を求めた。評価結果を試料無添加のコントロールにおける単位タンパク量当りのドーパメラニン生成量と比較し、表9に示す。
[Whitening action: Tyrosinase activity inhibitory action]
Normal human epidermal melanocytes were seeded in a 96-well microplate so as to be 3.0 × 10 4 cells per well. Medium 154S was used as the seeding medium. After culturing for 24 hours, the medium was replaced with Medium 154S to which the extract 1 was added so that the concentrations shown in Table 9 were obtained, followed by further culturing for 48 hours. Next, it was replaced with 75 μL of a phosphate buffer containing 1% by weight Triton-X to completely lyse the cells, and 50 μL was used as a crude enzyme solution. To the crude enzyme solution, 50 μL of a 0.05% by mass L-dopa-containing phosphate buffer as a substrate was added and allowed to stand at 37 ° C. for 2 hours. The absorbance at 405 nm was measured immediately after the addition of the substrate and at the end of the reaction, and the amount of dopamelanin produced was determined by introducing the difference between the two measured values into the following equation.
Amount of dopamelanin produced = {(405 nm value after reaction−405 nm value before reaction) −2.166} /5.238
In addition, the amount of protein in each well was measured with BCA Protein Assay Kit manufactured by PIERCE, and the amount of dopamelanin produced per unit protein amount was determined. The evaluation results are compared with the amount of dopamelanin produced per unit protein amount in the control with no sample added, and are shown in Table 9.

Figure 2012097028
Figure 2012097028

表9より明らかなように、タチギボウシ抽出物を添加した培地では、有意なチロシナーゼ活性阻害作用を示すことが明らかとなった。   As is clear from Table 9, it was revealed that the medium supplemented with the extract of Tachibobo exhibits a significant tyrosinase activity inhibitory action.

[美白作用:メラニン産生抑制作用]
B16マウスメラノーマ細胞(B16F0細胞)を1ディッシュ当り1.8×10個となるように90mmディッシュに播種した。播種培地には5質量%のウシ胎児血清(FBS)を添加したダルベッコ改変イーグル培地(DMEM)を用いた。24時間培養後、表11に示す各濃度となるように抽出物2を添加した5質量%FBS添加DMEM培地に交換し、さらに5日間培養した。培養終了後、トリプシン処理にて細胞をはがし、1.5mLマイクロチューブに移して遠心操作して細胞沈殿物を得た。得られた沈殿物は下記判定表を基にその黒化状況を肉眼判定した。評価ではネガティブコントロールに5質量%FBS添加DMEM培地、ポジティブコントロールに50mM乳酸ナトリウムを含有する5質量%FBS添加DMEM培地を用いた。これらの目視判定結果は判定5、及び判定1とし、サンプル判定の指標とした。目視判定は表10に示す通り、5段階評価した。また同時に、沈殿物に組織溶解剤(商品名Solvable)を添加して煮沸し、室温に戻して分光光度計(HITACHI製分光光度計U−3010)により500nmの吸光度を測定し、総メラニン量を求めた。評価結果を表11に示す。
[Whitening effect: Suppressing melanin production]
B16 mouse melanoma cells (B16F0 cells) were seeded in a 90 mm dish so that the number of B16 mouse melanoma cells was 1.8 × 10 4 per dish. Dulbecco's modified Eagle medium (DMEM) supplemented with 5% by weight fetal bovine serum (FBS) was used as the seeding medium. After culturing for 24 hours, the medium was replaced with a 5% by mass FBS-added DMEM medium to which the extract 2 was added so as to have each concentration shown in Table 11, and further cultured for 5 days. After completion of the culture, cells were peeled off by trypsin treatment, transferred to a 1.5 mL microtube, and centrifuged to obtain a cell precipitate. The obtained precipitate was visually determined based on the following determination table. In the evaluation, a 5% FBS-added DMEM medium containing 5% by mass FBS was used as a negative control, and a 5% FBS-added DMEM medium containing 50 mM sodium lactate was used as a positive control. These visual determination results were determined as determination 5 and determination 1, and used as an index for sample determination. As shown in Table 10, the visual judgment was evaluated in five stages. At the same time, the tissue solubilizer (trade name Solvable) was added to the precipitate, boiled, returned to room temperature, and the absorbance at 500 nm was measured with a spectrophotometer (HITACHI spectrophotometer U-3010) to determine the total amount of melanin. Asked. The evaluation results are shown in Table 11.

Figure 2012097028
Figure 2012097028

Figure 2012097028
Figure 2012097028

表11より明らかなように、タチギボウシ抽出物を添加することにより、有意なメラニン産生抑制作用を示すことが明らかとなった。   As is clear from Table 11, it was revealed that the addition of the guinea pig extract exhibits a significant melanin production inhibitory action.

表9、表11に示したとおり、タチギボウシ抽出物は、チロシナーゼ活性阻害作用およびメラニン産生抑制作用を示すことから、優れた抗酸化効果を発揮する。   As shown in Tables 9 and 11, the Tachigibo bovine extract exhibits an excellent antioxidant effect because it exhibits a tyrosinase activity inhibitory action and a melanin production inhibitory action.

Claims (5)

ユリ科ギボウシ属タチギボウシの抽出物を有効成分として含有する、抗老化剤。   An anti-aging agent comprising, as an active ingredient, an extract of the Lily family Hosta genus Tativiboshi. ユリ科ギボウシ属タチギボウシの抽出物を有効成分として含有する、抗酸化剤。   An antioxidant containing, as an active ingredient, an extract of the Lily family Hosta sp. ユリ科ギボウシ属タチギボウシの抽出物を有効成分として含有する、アルギナーゼ活性促進剤。   An arginase activity promoter comprising, as an active ingredient, an extract of a lily family Hosta genus Tachigiboushi. ユリ科ギボウシ属タチギボウシの抽出物を有効成分として含有する、痩身剤。   A slimming agent containing, as an active ingredient, an extract of the Lilyaceae genus Tachigiboushi. ユリ科ギボウシ属タチギボウシの抽出物を有効成分として含有する、美白剤。   A whitening agent containing, as an active ingredient, an extract of the Lilyaceae genus Tativogoshi.
JP2010245780A 2010-11-02 2010-11-02 Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent Pending JP2012097028A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2010245780A JP2012097028A (en) 2010-11-02 2010-11-02 Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010245780A JP2012097028A (en) 2010-11-02 2010-11-02 Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent

Publications (1)

Publication Number Publication Date
JP2012097028A true JP2012097028A (en) 2012-05-24

Family

ID=46389371

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010245780A Pending JP2012097028A (en) 2010-11-02 2010-11-02 Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent

Country Status (1)

Country Link
JP (1) JP2012097028A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108478672A (en) * 2018-05-31 2018-09-04 马秀群 A kind of composition and preparation method thereof for slowing down aging, boosting metabolism
CN108607026A (en) * 2018-05-31 2018-10-02 马秀群 A kind of reinvigoration, the composition and preparation method thereof to prolong life

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108478672A (en) * 2018-05-31 2018-09-04 马秀群 A kind of composition and preparation method thereof for slowing down aging, boosting metabolism
CN108607026A (en) * 2018-05-31 2018-10-02 马秀群 A kind of reinvigoration, the composition and preparation method thereof to prolong life

Similar Documents

Publication Publication Date Title
Yasin et al. The importance of some plant extracts as skin anti-aging resources: a review
KR101729209B1 (en) Development of skin-care products Based on Antioxidative effect of Abeliophyllum distichum Nakai
KR20110090803A (en) Cosmetic composition
JP5322599B2 (en) Antioxidant
KR20160125784A (en) Shiunko fermented oil and producing method thereof
KR20160009752A (en) Composition comprising Dendrobium moniliforme Extract for skin whitening and anti-wrinkle Effects, Functional food and Korean herb cosmetic manufactured by using them
Lee et al. Anti-inflammatory, barrier-protective, and antiwrinkle properties of Agastache rugosa Kuntze in human epidermal keratinocytes
JP5123092B2 (en) Topical skin preparation
WO2017100110A1 (en) Personal care composition and method of making the same
KR101872357B1 (en) Cosmetic composition for enhancing skin elasticity containing extract of rhamnus yoshinoi
JP5229728B2 (en) Arginase activity promoter, immunostimulant, anti-aging agent, whitening agent, antioxidant, and slimming agent
KR102350857B1 (en) Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water
JP2012097028A (en) Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent and whitening agent
KR101805872B1 (en) Cosmetic composition for improving skin wrinkle containing plant extract removed chlorophyll
JP2010150207A (en) Moisturizer, anti-aging agent, antioxidant, neutral fat-accumulation inhibitor, skin whitening agent, anti-inflammatory agent, immunostimulator, skin care preparation, oral medication
JP5610913B2 (en) Anti-aging agent, whitening agent, antioxidant, slimming agent, anti-inflammatory agent
JP5312731B2 (en) Topical skin preparation
JP2012041285A (en) Anti-aging agent, anti-oxidant, arginase activity accelerator, slimming agent, bleaching agent, and anti-inflammatory agent
JP5383001B2 (en) Skin preparations, moisturizers, anti-aging agents, antioxidants, anti-inflammatory agents, whitening agents, and slimming agents
JP2007277100A (en) Humectant, cell activator, dermal fibroblast activator, epidermal cell activator, collagen production accelerator, antioxidant, anti-aging agent, beautifully whitening agent or melanin production inhibitor
JP5247548B2 (en) Moisturizer, anti-aging agent, neutral fat accumulation inhibitor, whitening agent, anti-inflammatory agent, topical skin preparation, oral preparation
JP5610681B2 (en) Neutral fat accumulation inhibitor
JP2010195726A (en) Dermatopontin production promoter
KR101713486B1 (en) Cosmetic composition containing fermented extracts of Kigelia Africana Fruit, Canavalia Gladiata Pod and Corn Cob
KR101522369B1 (en) Cosmetic composition containing Ailanthi Radicis Cortex extract and Galium verum extract for anti-aging and whitening